[1] | Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease. Neurotoxicity Research |
[2] | The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of parkinson's disease. Journal of Neurochemistry |
[3] | Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: Modulator of toxicity of alpha-synuclein aggregates. ACS Chemical Neuroscience |
[4] | Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats. Journal of Neurochemistry |
[5] | Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry |
[6] | Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. Journal of Neurochemistry |
[7] | Tobacco smoke modulates ozone-induced toxicity in rat lungs and central nervous system. Inhalation Toxicology |
[8] | D-512 and D-440 as novel multifunctional dopamine agonists: Characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson’s disease animal model. ACS Chemical Neuroscience |
[9] | Mephedrone, an abused psychoactive component of bath salts and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. Journal of Neurochemistry |
[10] | Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. Journal of Neurochemistry |
[11] | The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum. Journal of Neurochemistry, |